Cubist Systematic Strategies’s Minerva Neurosciences NERV Stock Holding History

Cubist Systematic Strategies’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,200	Closed	-$51K	–	3031
2021 Q1	$51K	Buy	2,200 +725	+49%	+$18.1K	﹤0.01%	2733
2020 Q4	$28K	Sell	1,475 -762	-34%	-$19.2K	﹤0.01%	2490
2020 Q3	$57K	Sell	2,237 -1,875	-46%	-$50.7K	﹤0.01%	2353
2020 Q2	$119K	Buy	+4,112	New	+$241K	﹤0.01%	2165
2020 Q1	–	Sell	-2,100	Closed	-$119K	–	2334
2019 Q4	$119K	Buy	2,100 +1,784	+565%	+$78.7K	﹤0.01%	2154
2019 Q3	$20K	Buy	+316	New	+$17.9K	﹤0.01%	2124
2019 Q1	–	Sell	-585	Closed	-$32K	–	2362
2018 Q4	$32K	Sell	585 -50	-8%	-$3.66K	﹤0.01%	1917
2018 Q3	$64K	Buy	+635	New	+$47.7K	﹤0.01%	1672

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cubist Systematic Strategies's NERV Position: Q2 2021 in Review

Cubist Systematic Strategies sold out of Minerva Neurosciences (NERV) in Q2 2021, closing a stake of 2,200 shares — an estimated $51K sold.

Cubist Systematic Strategies first reported a position in NERV in Q3 2018 and held it in 8 quarters. The position peaked at $119K in Q2 2020. 68 funds tracked by Wall St. Rank hold NERV as of Q2 2021.

Cubist Systematic Strategies reported no remaining Minerva Neurosciences position as of Q2 2021 after selling out during the quarter.
Cubist Systematic Strategies sold 2,200 Minerva Neurosciences shares in Q2 2021, an estimated $51K.
Cubist Systematic Strategies first reported a position in Minerva Neurosciences in Q3 2018 and held it in 8 quarters.
Cubist Systematic Strategies's Minerva Neurosciences position peaked at $119K in Q2 2020.
68 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2021.

Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.